Making a Difference for Cancer Patients with Hybrid and External Control Arms in Clinical Trials
While the traditional approach of studying control and intervention arms concurrently is an effective way to bring new treatment options to patients, the growing availability of high-quality real-world data (RWD) is changing the way we can accelerate results.
